RxDoctor Payments Data
★ My doctorsLook up a doctor →

Christopher Stalberg

Internal Medicine · Paradise Valley, AZNPI 1346347770

Payments from drug & device makers

$3,786in general payments, 2019–2025

Across 238 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$880
  • Johnson & Johnson$278
  • AbbVie$263
  • Pfizer$262
  • Boehringer Ingelheim$250
  • Abbott$247
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$3,777100%
  • Education$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)65$880
Johnson & Johnson(2 entities)20$278
AbbVie(2 entities)18$263
Pfizer17$262
Boehringer Ingelheim12$250
Abbott12$247
AstraZeneca10$136
Novo Nordisk8$123
Astellas Pharma US Inc6$118
Boston Scientific5$116
Novartis5$96
Lilly USA, LLC6$80
Nestle Healthcare Nutrition Inc.4$79
Sunovion Pharmaceuticals Inc.5$70
Edwards Lifesciences3$66
Merck3$61
Amarin Pharma, Inc.4$58
Topcon Healthcare Solutions, Inc.1$46
Daiichi Sankyo Inc.3$43
Lucid Diagnostics Inc.2$41
Vanda Pharmaceuticals Inc.2$40
Teva Pharmaceuticals USA, Inc.2$34
Phadia US Inc.2$34
Exact Sciences2$32
GSK2$32
Radius Health, Inc.2$31
Medtronic(2 entities)2$27
Kowa Pharmaceuticals America, Inc.2$24
Fresenius Kabi USA, LLC1$23
Harmony Biosciences LLC1$22
Esperion Therapeutics, Inc.1$21
Bardy Diagnostics, Inc.1$20
GE HealthCare1$19
Nalu Medical, Inc.1$19
Genentech USA, Inc.1$18
Ultragenyx Pharmaceutical Inc.1$16
Eisai Inc.1$14
Paratek Pharmaceuticals, Inc.1$13
Acadia Pharmaceuticals Inc1$13
Mayne Pharma Commercial LLC1$12
Sanofi-aventis U.S. LLC1$11

How this compares

$3,786 in reported general payments places this provider in the 90th percentile of 2,212 internal medicine providers in Arizona.

See all internal medicine providers in Arizona →

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban44$47,006
OzempicSemaglutide31$45,148
XareltoRivaroxaban16$23,098
Repatha SureclickEvolocumab15$13,345
Atorvastatin Calcium274$3,293
Levothyroxine Sodium239$2,599
Metoprolol Succinate116$2,256
Rosuvastatin Calcium126$1,966
Losartan Potassium137$1,958
Simvastatin193$1,912
Memantine Hcl28$1,907
Omeprazole140$1,871
Pantoprazole Sodium74$1,771
SynthroidLevothyroxine Sodium27$1,576
Lisinopril156$1,368

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$262$47,00644 claims
Novo NordiskOzempic$123$45,14831 claims
Johnson & JohnsonXarelto$278$23,09816 claims
AbbVieSynthroid$263$1,57627 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,212 internal medicine providers in Arizona.

Other internal medicine in Paradise Valley

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →